0001013606-19-000022.txt : 20190102 0001013606-19-000022.hdr.sgml : 20190102 20190102210328 ACCESSION NUMBER: 0001013606-19-000022 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181230 FILED AS OF DATE: 20190102 DATE AS OF CHANGE: 20190102 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Thompson Matthew CENTRAL INDEX KEY: 0001740988 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-28440 FILM NUMBER: 19503460 MAIL ADDRESS: STREET 1: 2 MUSICK CITY: IRVINE STATE: CA ZIP: 92618 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ENDOLOGIX INC /DE/ CENTRAL INDEX KEY: 0001013606 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 680328265 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2 MUSICK CITY: IRVINE STATE: CA ZIP: 92618 BUSINESS PHONE: 9495984741 MAIL ADDRESS: STREET 1: 2 MUSICK CITY: IRVINE STATE: CA ZIP: 92618 FORMER COMPANY: FORMER CONFORMED NAME: RADIANCE MEDICAL SYSTEMS INC /DE/ DATE OF NAME CHANGE: 19990122 FORMER COMPANY: FORMER CONFORMED NAME: CARDIOVASCULAR DYNAMICS INC DATE OF NAME CHANGE: 19960506 4 1 wf-form4_154648099216564.xml FORM 4 X0306 4 2018-12-30 0 0001013606 ENDOLOGIX INC /DE/ ELGX 0001740988 Thompson Matthew 2 MUSICK IRVINE CA 92618 0 1 0 0 Chief Medical Officer Common Stock 2018-12-30 4 D 0 15000 0 D 53062 D Common Stock 2018-12-30 4 A 0 470115 0 A 523177 D Option to Purchase 0.7445 2018-12-30 4 A 0 225621 0.7445 A 2019-12-30 2028-12-30 Common Stock 225621.0 225621 D Shares subject to this Form 4 were granted as part of a performance restricted stock unit granted May 31, 2017. All shares granted were forfeited as of March 13, 2018 due to the single performance milestone being deemed not achievable by the Company. This forfeiture was not previously reported to the Securities and Exchange Commission, as the number of shares was deemed immaterial by the issuer. The time-based restricted stock unit award shall vest in three equal annual installments on December 30, 2019, December 30, 2020 and December 30, 2021 and shall settle in shares of common stock on each of those dates. 100% of the option award shall vest on December 30, 2019. Matthew Thompson by Timothy N. Brady Attorney-in-Fact for Reporting Person 2019-01-02